Citadel Advisors
SOPH icon

Citadel Advisors’s SOPHiA GENETICS SOPH Stock Holding History

Citadel Advisors’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,320
Closed -$58.6K – 13974
2025
Q3 		$58.6K Sell
12,320
-26,791
-68% -$92.1K ﹤0.01% 12116
2025
Q2 		$121K Buy
39,111
+26,976
+222% +$80.4K ﹤0.01% 11152
2025
Q1 		$40.3K Sell
12,135
-8,451
-41% -$29.7K ﹤0.01% 12538
2024
Q4 		$64.2K Buy
20,586
+5,094
+33% +$17.3K ﹤0.01% 12100
2024
Q3 		$56.3K Buy
+15,492
New +$62.9K ﹤0.01% 11778
2024
Q1 		– Sell
-20,174
Closed -$95K – 15382
2023
Q4 		$95K Sell
20,174
-2,805
-12% -$10.5K ﹤0.01% 10994
2023
Q3 		$58.6K Sell
22,979
-23,710
-51% -$75.2K ﹤0.01% 11565
2023
Q2 		$209K Sell
46,689
-20,599
-31% -$93.1K ﹤0.01% 9787
2023
Q1 		$334K Buy
67,288
+36,012
+115% +$117K ﹤0.01% 9158
2022
Q4 		$64.4K Sell
31,276
-27,035
-46% -$60.7K ﹤0.01% 11814
2022
Q3 		$153K Buy
+58,311
New +$204K ﹤0.01% 10679
2022
Q1 		– Sell
-14,194
Closed -$200K – 14508
2021
Q4 		$200K Buy
+14,194
New +$209K ﹤0.01% 11855

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $369M AUM 45.79% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Citadel Advisors's SOPH Position: Q4 2025 in Review

Citadel Advisors sold out of SOPHiA GENETICS (SOPH) in Q4 2025, closing a stake of 12,320 shares — an estimated $58.6K sold.

Citadel Advisors first reported a position in SOPH in Q4 2021 and held it in 12 quarters. The position peaked at $334K in Q1 2023. 42 funds tracked by Wall St. Rank hold SOPH as of Q4 2025.

  • Citadel Advisors reported no remaining SOPHiA GENETICS position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 12,320 SOPHiA GENETICS shares in Q4 2025, an estimated $58.6K.
  • Citadel Advisors first reported a position in SOPHiA GENETICS in Q4 2021 and held it in 12 quarters.
  • Citadel Advisors's SOPHiA GENETICS position peaked at $334K in Q1 2023.
  • 42 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.